Healthcare provider profile · identity verified

Steven H Gray, MD

Family Practice · NEW ALBANY, IN · NPI 1326033887

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	225	83
Amlodipine Besylate	Amlodipine Besylate	223	82
Atorvastatin Calcium	Atorvastatin Calcium	223	89
Pantoprazole Sodium	Pantoprazole Sodium	137	45
Lisinopril	Lisinopril	130	46
Levothyroxine Sodium	Levothyroxine Sodium	121	42
Omeprazole	Omeprazole	97	32
Metoprolol Succinate	Metoprolol Succinate	96	37
Duloxetine Hcl	Duloxetine Hcl	93	26
Trazodone Hcl	Trazodone Hcl	93	25
Gabapentin	Gabapentin	91	31
Losartan Potassium	Losartan Potassium	82	28
Metformin Hcl	Metformin Hcl	80	28
Metoprolol Tartrate	Metoprolol Tartrate	77	22
Furosemide	Furosemide	74	24
Potassium Chloride	Potassium Chloride	67	23
Pravastatin Sodium	Pravastatin Sodium	61	17
Albuterol Sulfate Hfa	Albuterol Sulfate	57	28
Fluticasone Propionate	Fluticasone Propionate	55	29
Clopidogrel	Clopidogrel Bisulfate	47	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	13
Sertraline Hcl	Sertraline Hcl	45	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	12
Clonazepam	Clonazepam	42	suppressed
Eliquis	Apixaban	42	13
Metformin Hcl Er	Metformin Hcl	42	20
Meloxicam	Meloxicam	39	12
Allopurinol	Allopurinol	38	12
Bupropion Xl	Bupropion Hcl	38	18
Ezetimibe	Ezetimibe	37	12
Glimepiride	Glimepiride	37	14
Simvastatin	Simvastatin	36	11
Spironolactone	Spironolactone	36	13
Tramadol Hcl	Tramadol Hcl	35	13
Valsartan	Valsartan	35	11
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	14
Prednisone	Prednisone	34	25
Alendronate Sodium	Alendronate Sodium	33	14
Farxiga	Dapagliflozin Propanediol	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	12
Ozempic	Semaglutide	32	11
Hydrochlorothiazide	Hydrochlorothiazide	30	15
Celecoxib	Celecoxib	29	suppressed
Carvedilol	Carvedilol	28	12
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Alprazolam	Alprazolam	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Famotidine	Famotidine	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Ondansetron Odt	Ondansetron	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Temazepam	Temazepam	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Cephalexin	Cephalexin	15	suppressed
Glipizide	Glipizide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Atenolol	Atenolol	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error